{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:21:07Z","timestamp":1789924867344,"version":"4.0.1"},"publisher-location":"Boston, MA","reference-count":185,"publisher":"Springer US","isbn-type":[{"value":"9781441982155","type":"print"},{"value":"9781441982162","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-4419-8216-2_7","type":"book-chapter","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T01:43:08Z","timestamp":1312681388000},"page":"82-102","source":"Crossref","is-referenced-by-count":63,"title":["Epigenetic Dysregulation of Epstein-Barr Virus Latency and Development of Autoimmune Disease"],"prefix":"10.1007","author":[{"given":"Hans Helmut","family":"Niller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Minarovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","volume":"10","author":"MP Thompson","year":"2004","unstructured":"Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004; 10:803\u2013821.","journal-title":"Clin Cancer Res"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/978-0-387-34127-9_8","volume-title":"Latency Strategies of Herpesviruses","author":"HH Niller","year":"2007","unstructured":"Niller HH, Wolf H, Minarovits J. Epstein-Barr Virus. In: Minarovits J, Gonczol E, Valyi-Nagy T, eds. Latency Strategies of Herpesviruses. New York: Springer, 2007:154\u2013191."},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/08916930802024772","volume":"41","author":"HH Niller","year":"2008","unstructured":"Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008; 41:298\u2013328.","journal-title":"Autoimmunity"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"e1000496","DOI":"10.1371\/journal.ppat.1000496","volume":"5","author":"V Hadinoto","year":"2009","unstructured":"Hadinoto V, Shapiro M, Sun CC et al. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009; 5:e1000496.","journal-title":"PLoS Pathog"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1098\/rstb.2000.0783","volume":"356","author":"DH Crawford","year":"2001","unstructured":"Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:461\u2013473.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"7_CR6","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1128\/JVI.78.10.5194-5204.2004","volume":"78","author":"D Hochberg","year":"2004","unstructured":"Hochberg D, Souza T, Catalina M et al. Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 2004; 78:5194\u20135204.","journal-title":"J Virol"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1128\/JVI.68.11.7374-7385.1994","volume":"68","author":"RJ Tierney","year":"1994","unstructured":"Tierney RJ, Steven N, Young LS et al. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 1994; 68:7374\u20137385.","journal-title":"J Virol"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1056\/NEJM197911223012101","volume":"301","author":"G Tosato","year":"1979","unstructured":"Tosato G, Magrath I, Koski I et al. Activation of suppressor T-cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med 1979; 301:1133\u20131137.","journal-title":"N Engl J Med"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1098\/rstb.2000.0784","volume":"356","author":"DJ Moss","year":"2001","unstructured":"Moss DJ, Burrows SR, Silins SL et al. The immunology of Epstein-Barr virus infection. Philos Trans R Soc Lond B Biol Sci 2001; 356:475\u2013488.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/blood.V98.13.3739","volume":"98","author":"SL Silins","year":"2001","unstructured":"Silins SL, Sherritt MA, Silleri JM et al. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 2001; 98:3739\u20133744.","journal-title":"Blood"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350:1328\u20131337.","journal-title":"N Engl J Med"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"18093","DOI":"10.1073\/pnas.0509311102","volume":"102","author":"TA Souza","year":"2005","unstructured":"Souza TA, Stollar BD, Sullivan JL et al. Peripheral B-cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B-cells. Proc Natl Acad Sci USA 2005; 102:18093\u201318098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)00048-0","volume":"13","author":"J Kurth","year":"2000","unstructured":"Kurth J, Spieker T, Wustrow J et al. EBV-infected B-cells in infectious mononucleosis: viral strategies for spreading in the B-cell compartment and establishing latency. Immunity 2000; 13:485\u2013495.","journal-title":"Immunity"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1073\/pnas.2627966100","volume":"100","author":"J Kurth","year":"2003","unstructured":"Kurth J, Hansmann ML, Rajewsky K et al. Epstein-Barr virus-infected B-cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction. Proc Natl Acad Sci USA 2003; 100:4730\u20134735.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1128\/JVI.02609-08","volume":"83","author":"JE Roughan","year":"2009","unstructured":"Roughan JE, Thorley-Lawson DA. The intersection of Epstein-Barr virus with the germinal center. J Virol 2009; 83:3968\u20133976.","journal-title":"J Virol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1128\/JVI.01780-09","volume":"84","author":"JE Roughan","year":"2010","unstructured":"Roughan JE, Torgbor C, Thorley-Lawson DA. Germinal center B-cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol 2010; 84:1158\u20131168.","journal-title":"J Virol"},{"key":"7_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2567.2003.01601.x","volume":"108","author":"B Ehlin-Henriksson","year":"2003","unstructured":"Ehlin-Henriksson B, Gordon J, Klein G. B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology 2003; 108:427\u2013430.","journal-title":"Immunology"},{"key":"7_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1126\/science.286.5438.300","volume":"286","author":"J Uchida","year":"1999","unstructured":"Uchida J, Yasui T, Takaoka-Shichijo Y et al. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 1999; 286:300\u2013303.","journal-title":"Science"},{"key":"7_CR19","first-page":"173","volume-title":"Advances in Viral Oncology","author":"GM Lenoir","year":"1987","unstructured":"Lenoir GM, Bornkamm G. Burkitt\u2019s Lymphoma, a human cancer model for the study of the multistep dvelopment of cancer: proposal for a new scenario. In: Klein G, ed. Advances in Viral Oncology. New York: Raven Press, 1 1987:173\u2013206."},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<326::AID-PATH242>3.0.CO;2-N","volume":"187","author":"I Araujo","year":"1999","unstructured":"Araujo I, Foss HD, Hummel M et al. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma. J Pathol 1999; 187:326\u2013330.","journal-title":"J Pathol"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.mehy.2003.11.001","volume":"62","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Ilg K et al. EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 2004; 62:387\u2013391.","journal-title":"Med Hypotheses"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1128\/JVI.63.2.938-942.1989","volume":"63","author":"M Marschall","year":"1989","unstructured":"Marschall M, Leser U, Seibl R et al. Identification of proteins encoded by Epstein-Barr virus trans-activator genes. J Virol 1989; 63:938\u2013942.","journal-title":"J Virol"},{"key":"7_CR23","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/JVI.65.5.2237-2244.1991","volume":"65","author":"AJ Sinclair","year":"1991","unstructured":"Sinclair AJ, Brimmell M, Shanahan F et al. Pathways of activation of the Epstein-Barr virus productive cycle. J Virol 1991; 65:2237\u20132244.","journal-title":"J Virol"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.tim.2004.09.006","volume":"12","author":"HH Niller","year":"2004","unstructured":"Niller HH, Salamon D, Banati F et al. The LCR of EBV makes Burkitt\u2019s lymphoma endemic. Trends Microbiol 2004; 12:495\u2013499.","journal-title":"Trends Microbiol"},{"key":"7_CR25","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S Pfeffer","year":"2004","unstructured":"Pfeffer S, Zavolan M, Grasser FA et al. Identification of virus-encoded microRNAs. Science 2004; 304:734\u2013736.","journal-title":"Science"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","volume":"2","author":"X Cai","year":"2006","unstructured":"Cai X, Schafer A, Lu S et al. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2006; 2:e23.","journal-title":"PLoS Pathog"},{"key":"7_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1261\/rna.2326106","volume":"12","author":"A Grundhoff","year":"2006","unstructured":"Grundhoff A, Sullivan CS, Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006; 12:733\u2013750.","journal-title":"RNA"},{"key":"7_CR28","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1128\/JVI.01689-08","volume":"83","author":"JY Zhu","year":"2009","unstructured":"Zhu JY, Pfuhl T, Motsch N et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol 2009; 83:3333\u20133341.","journal-title":"J Virol"},{"issue":"Pt 4","key":"7_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1099\/0022-1317-70-4-837","volume":"70","author":"RW Honess","year":"1989","unstructured":"Honess RW, Gompels UA, Barrell BG et al. Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J Gen Virol 1989; 70(Pt 4):837\u2013855.","journal-title":"J Gen Virol"},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/blood.V90.11.4480","volume":"90","author":"KD Robertson","year":"1997","unstructured":"Robertson KD, Ambinder RF. Methylation of the Epstein-Barr virus genome in normal lymphocytes. Blood 1997; 90:4480\u20134484.","journal-title":"Blood"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1128\/JVI.73.12.9959-9968.1999","volume":"73","author":"EJ Paulson","year":"1999","unstructured":"Paulson EJ, Speck SH. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol 1999; 73:9959\u20139968.","journal-title":"J Virol"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1099\/0022-1317-72-7-1591","volume":"72","author":"J Minarovits","year":"1991","unstructured":"Minarovits J, Minarovits-Kormuta S, Ehlin-Henriksson B et al. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol 1991; 72:1591\u20131599.","journal-title":"J Gen Virol"},{"key":"7_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0065-230X(03)01004-2","volume":"89","author":"H Li","year":"2003","unstructured":"Li H, Minarovits J. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv Cancer Res 2003; 89:133\u2013156.","journal-title":"Adv Cancer Res"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/3-540-31181-5_5","volume":"310","author":"J Minarovits","year":"2006","unstructured":"Minarovits J. Epigenotypes of latent herpesvirus genomes. Curr Top Microbiol Immunol 2006; 310:61\u201380.","journal-title":"Curr Top Microbiol Immunol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1099\/0022-1317-70-11-2989","volume":"70","author":"I Ernberg","year":"1989","unstructured":"Ernberg I, Falk K, Minarovits J et al. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Gen Virol 1989; 70:2989\u20133002.","journal-title":"J Gen Virol"},{"key":"7_CR36","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1099\/0022-1317-73-7-1687","volume":"73","author":"J Minarovits","year":"1992","unstructured":"Minarovits J, Hu LF, Marcsek Z et al. RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. J Gen Virol 1992; 73:1687\u20131692.","journal-title":"J Gen Virol"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1073\/pnas.89.3.905","volume":"89","author":"E Altiok","year":"1992","unstructured":"Altiok E, Minarovits J, Hu LF et al. Host-cell-phenotype-dependent control of the BCR2\/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2\u20136. Proc Natl Acad Sci USA 1992; 89:905\u2013909.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JVI.41.2.376-389.1982","volume":"41","author":"JR Arrand","year":"1982","unstructured":"Arrand JR, Rymo L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol 1982; 41:376\u2013389.","journal-title":"J Virol"},{"key":"7_CR39","doi-asserted-by":"publisher","first-page":"33871","DOI":"10.1074\/jbc.M600468200","volume":"281","author":"ZA Felton-Edkins","year":"2006","unstructured":"Felton-Edkins ZA, Kondrashov A, Karali D et al. Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. J Biol Chem 2006; 281:33871\u201333880.","journal-title":"J Biol Chem"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1073\/pnas.78.2.805","volume":"78","author":"MR Lerner","year":"1981","unstructured":"Lerner MR, Andrews NC, Miller G et al. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1981; 78:805\u2013809.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR41","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1073\/pnas.91.8.3463","volume":"91","author":"DP Toczyski","year":"1994","unstructured":"Toczyski DP, Matera AG, Ward DC et al. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc Natl Acad Sci USA 1994; 91:3463\u20133467.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/nar\/19.2.243","volume":"19","author":"PA Clarke","year":"1991","unstructured":"Clarke PA, Schwemmle M, Schickinger J et al. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991; 19:243\u2013248.","journal-title":"Nucleic Acids Res"},{"key":"7_CR43","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1111\/j.1432-1033.2004.04099.x","volume":"271","author":"A Elia","year":"2004","unstructured":"Elia A, Vyas J, Laing KG et al. Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein-Barr virus small RNA EBER-1. Eur J Biochem 2004; 271:1895\u20131905.","journal-title":"Eur J Biochem"},{"key":"7_CR44","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","volume":"73","author":"J Komano","year":"1999","unstructured":"Komano J, Maruo S, Kurozumi K et al. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line Akata. J Virol 1999; 73:9827\u20139831.","journal-title":"J Virol"},{"key":"7_CR45","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1128\/JVI.74.21.10223-10228.2000","volume":"74","author":"IK Ruf","year":"2000","unstructured":"Ruf IK, Rhyne PW, Yang C et al. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 2000; 74:10223\u201310228.","journal-title":"J Virol"},{"key":"7_CR46","doi-asserted-by":"publisher","first-page":"14562","DOI":"10.1128\/JVI.79.23.14562-14569.2005","volume":"79","author":"IK Ruf","year":"2005","unstructured":"Ruf IK, Lackey KA, Warudkar S et al. Protection from interferon-induced apoptosis by epstein-barr virus small RNAs is not mediated by inhibition of PKR. J Virol 2005; 79:14562\u201314569.","journal-title":"J Virol"},{"key":"7_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biocel.2005.09.014","volume":"38","author":"MJ Clemens","year":"2006","unstructured":"Clemens MJ. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. Int J Biochem Cell Biol 2006; 38:164\u2013169.","journal-title":"Int J Biochem Cell Biol"},{"key":"7_CR48","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1084\/jem.20081761","volume":"206","author":"D Iwakiri","year":"2009","unstructured":"Iwakiri D, Zhou L, Samanta M et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 2009; 206:2091\u20132099.","journal-title":"J Exp Med"},{"key":"7_CR49","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1128\/JVI.63.6.2644-2649.1989","volume":"63","author":"B Sugden","year":"1989","unstructured":"Sugden B, Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J Virol 1989; 63:2644\u20132649.","journal-title":"J Virol"},{"key":"7_CR50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/j.1460-2075.1992.tb05157.x","volume":"11","author":"S Jankelevich","year":"1992","unstructured":"Jankelevich S, Kolman JL, Bodnar JW et al. A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J 1992; 11:1165\u20131176.","journal-title":"EMBO J"},{"key":"7_CR51","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JVI.68.6.4067-4071.1994","volume":"68","author":"T Middleton","year":"1994","unstructured":"Middleton T, Sugden B. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol 1994; 68:4067\u20134071.","journal-title":"J Virol"},{"key":"7_CR52","doi-asserted-by":"publisher","first-page":"11249","DOI":"10.1128\/JVI.75.22.11249-11252.2001","volume":"75","author":"RE White","year":"2001","unstructured":"White RE, Wade-Martins R, James MR. Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B-cells. J Virol 2001; 75:11249\u201311252.","journal-title":"J Virol"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1128\/JVI.75.13.6235-6241.2001","volume":"75","author":"B Wensing","year":"2001","unstructured":"Wensing B, Stuhler A, Jenkins P et al. Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP. J Virol 2001; 75:6235\u20136241.","journal-title":"J Virol"},{"key":"7_CR54","doi-asserted-by":"publisher","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","volume":"94","author":"J Levitskaya","year":"1997","unstructured":"Levitskaya J, Sharipo A, Leonchiks A et al. Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 1997; 94:12616\u201312621.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR55","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1084\/jem.20040730","volume":"199","author":"C Munz","year":"2004","unstructured":"Munz C. Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T-cell target. J Exp Med 2004; 199:1301\u20131304.","journal-title":"J Exp Med"},{"key":"7_CR56","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awl067","volume":"129","author":"JD Lunemann","year":"2006","unstructured":"Lunemann JD, Edwards N, Muraro PA et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T-cells in multiple sclerosis. Brain 2006; 129:1493\u20131506.","journal-title":"Brain"},{"key":"7_CR57","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/JVI.44.3.834-844.1982","volume":"44","author":"M Rabson","year":"1982","unstructured":"Rabson M, Gradoville L, Heston L et al. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol 1982; 44:834\u2013844.","journal-title":"J Virol"},{"key":"7_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/340393a0","volume":"340","author":"W Hammerschmidt","year":"1989","unstructured":"Hammerschmidt W, Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 1989; 340:393\u2013397.","journal-title":"Nature"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1073\/pnas.90.20.9237","volume":"90","author":"PD Ling","year":"1993","unstructured":"Ling PD, Rawlins DR, Hayward SD. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci USA 1993; 90:9237\u20139241.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR60","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/JVI.64.3.1002-1013.1990","volume":"64","author":"M Cordier","year":"1990","unstructured":"Cordier M, Calender A, Billaud M et al. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J Virol 1990; 64:1002\u20131013.","journal-title":"J Virol"},{"key":"7_CR61","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/JVI.64.7.3407-3416.1990","volume":"64","author":"F Wang","year":"1990","unstructured":"Wang F, Tsang SF, Kurilla MG et al. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 1990; 64:3407\u20133416.","journal-title":"J Virol"},{"key":"7_CR62","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1128\/JVI.65.12.6826-6837.1991","volume":"65","author":"JB Mannick","year":"1991","unstructured":"Mannick JB, Cohen JI, Birkenbach M et al. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J Virol 1991; 65:6826\u20136837.","journal-title":"J Virol"},{"key":"7_CR63","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1128\/JVI.71.9.6611-6618.1997","volume":"71","author":"S Harada","year":"1997","unstructured":"Harada S, Kieff E. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 1997; 71:6611\u20136618.","journal-title":"J Virol"},{"key":"7_CR64","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1128\/JVI.71.9.6619-6628.1997","volume":"71","author":"F Nitsche","year":"1997","unstructured":"Nitsche F, Bell A, Rickinson A. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. J Virol 1997; 71:6619\u20136628.","journal-title":"J Virol"},{"key":"7_CR65","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.67.4.2014-2025.1993","volume":"67","author":"B Tomkinson","year":"1993","unstructured":"Tomkinson B, Robertson E, Kieff E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 1993; 67:2014\u20132025.","journal-title":"J Virol"},{"key":"7_CR66","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/JVI.66.5.2893-2903.1992","volume":"66","author":"B Tomkinson","year":"1992","unstructured":"Tomkinson B, Kieff E. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J Virol 1992; 66:2893\u20132903.","journal-title":"J Virol"},{"key":"7_CR67","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1128\/JVI.70.9.5909-5915.1996","volume":"70","author":"L Waltzer","year":"1996","unstructured":"Waltzer L, Perricaudet M, Sergeant A et al. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol 1996; 70:5909\u20135915.","journal-title":"J Virol"},{"key":"7_CR68","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/JVI.70.5.3068-3074.1996","volume":"70","author":"ES Robertson","year":"1996","unstructured":"Robertson ES, Lin J, Kieff E. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B and 3C interact with RBPJ(kappa). J Virol 1996; 70:3068\u20133074.","journal-title":"J Virol"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.1128\/JVI.00854-06","volume":"80","author":"A Chen","year":"2006","unstructured":"Chen A, Zhao B, Kieff E et al. EBNA-3B-and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 2006; 80:10139\u201310150.","journal-title":"J Virol"},{"key":"7_CR70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1006\/scbi.2001.0414","volume":"11","author":"P Smith","year":"2001","unstructured":"Smith P. Epstein-Barr virus complementary strand transcripts (CSTs\/BARTs) and cancer. Semin Cancer Biol 2001; 11:469\u2013476.","journal-title":"Semin Cancer Biol"},{"key":"7_CR71","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1099\/vir.0.006551-0","volume":"90","author":"M Mozaini Al","year":"2009","unstructured":"Al Mozaini M, Bodelon G, Karstegl CE et al. Epstein-Barr virus BART gene expression. J Gen Virol 2009; 90:307\u2013316.","journal-title":"J Gen Virol"},{"key":"7_CR72","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JVI.69.2.1132-1141.1995","volume":"69","author":"RH Sadler","year":"1995","unstructured":"Sadler RH, Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 1995; 69:1132\u20131141.","journal-title":"J Virol"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1099\/vir.0.19054-0","volume":"84","author":"O Jesus de","year":"2003","unstructured":"de Jesus O, Smith PR, Spender LC et al. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 2003; 84:1443\u20131450.","journal-title":"J Gen Virol"},{"key":"7_CR74","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","volume":"171","author":"B He","year":"2003","unstructured":"He B, Raab-Traub N, Casali P et al. EBV-encoded latent membrane protein 1 choperates with BAF\/BLyS and APRIL to induce T-cell-independent Ig heavy chain class switching. J Immunol 2003; 171:5215\u20135224.","journal-title":"J Immunol"},{"key":"7_CR75","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1128\/JVI.68.11.6947-6958.1994","volume":"68","author":"G Laux","year":"1994","unstructured":"Laux G, Dugrillon F, Eckert C et al. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J Virol 1994; 68:6947\u20136958.","journal-title":"J Virol"},{"key":"7_CR76","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1128\/JVI.69.7.4577-4581.1995","volume":"69","author":"RH Sadler","year":"1995","unstructured":"Sadler RH, Raab-Traub N. The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-less promoter within the first terminal repeat. J Virol 1995; 69:4577\u20134581.","journal-title":"J Virol"},{"key":"7_CR77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/JVI.51.2.411-419.1984","volume":"51","author":"S Fennewald","year":"1984","unstructured":"Fennewald S, van Santen V, Kieff E. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 1984; 51:411\u2013419.","journal-title":"J Virol"},{"key":"7_CR78","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1099\/vir.0.82790-0","volume":"88","author":"MP Rechsteiner","year":"2007","unstructured":"Rechsteiner MP, Berger C, Weber M et al. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt\u2019s lymphoma Akata cells. J Gen Virol 2007; 88:1454\u20131459.","journal-title":"J Gen Virol"},{"key":"7_CR79","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1128\/JVI.01723-07","volume":"82","author":"MP Rechsteiner","year":"2008","unstructured":"Rechsteiner MP, Berger C, Zauner L et al. Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol 2008; 82:1739\u20131747.","journal-title":"J Virol"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.it.2007.03.002","volume":"28","author":"M Swanson-Mungerson","year":"2007","unstructured":"Swanson-Mungerson M, Longnecker R. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol 2007; 28:213\u2013218.","journal-title":"Trends Immunol"},{"key":"7_CR81","doi-asserted-by":"publisher","first-page":"11668","DOI":"10.1158\/0008-5472.CAN-06-2194","volume":"66","author":"CL Tsai","year":"2006","unstructured":"Tsai CL, Li HP, Lu YJ et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 2006; 66:11668\u201311676.","journal-title":"Cancer Res"},{"key":"7_CR82","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","volume":"69","author":"R Hino","year":"2009","unstructured":"Hino R, Uozaki H, Murakami N et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 2009; 69:2766\u20132774.","journal-title":"Cancer Res"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-07-5126","volume":"68","author":"T Xia","year":"2008","unstructured":"Xia T, O\u2019Hara A, Araujo I et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 2008; 68:1436\u20131442.","journal-title":"Cancer Res"},{"key":"7_CR84","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1593\/neo.09888","volume":"11","author":"RW Lung","year":"2009","unstructured":"Lung RW, Tong JH, Sung YM et al. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 2009; 11:1174\u20131184.","journal-title":"Neoplasia"},{"key":"7_CR85","doi-asserted-by":"publisher","first-page":"16164","DOI":"10.1073\/pnas.0702896104","volume":"104","author":"AK Lo","year":"2007","unstructured":"Lo AK, To KF, Lo KW et al. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci USA 2007; 104:16164\u201316169.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR86","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/nar\/gkm1080","volume":"36","author":"S Barth","year":"2008","unstructured":"Barth S, Pfuhl T, Mamiani A et al. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 2008; 36:666\u2013675.","journal-title":"Nucleic Acids Res"},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1084\/jem.20072581","volume":"205","author":"EY Choy","year":"2008","unstructured":"Choy EY, Siu KL, Kok KH et al. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 2008; 205:2551\u20132560.","journal-title":"J Exp Med"},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chom.2009.03.003","volume":"5","author":"D Nachmani","year":"2009","unstructured":"Nachmani D, Stern-Ginossar N, Sarid R et al. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009; 5:376\u2013385.","journal-title":"Cell Host Microbe"},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semcancer.2009.02.012","volume":"19","author":"HH Niller","year":"2009","unstructured":"Niller HH, Wolf H, Minarovits J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol 2009; 19:158\u2013164.","journal-title":"Semin Cancer Biol"},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.it.2009.03.007","volume":"30","author":"JD Lunemann","year":"2009","unstructured":"Lunemann JD, Munz C. EBV in MS: guilty by association? Trends Immunol 2009; 30:243\u2013248.","journal-title":"Trends Immunol"},{"key":"7_CR91","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","volume":"24","author":"MP Pender","year":"2003","unstructured":"Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003; 24:584\u2013588.","journal-title":"Trends Immunol"},{"key":"7_CR92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00281-006-0031-6","volume":"28","author":"M Wong","year":"2006","unstructured":"Wong M, Tsao BP. Current topics in human SLE genetics. Springer Semin Immunopathol 2006; 28:97\u2013107.","journal-title":"Springer Semin Immunopathol"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaut.2009.03.007","volume":"33","author":"A Hewagama","year":"2009","unstructured":"Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33:3\u201311.","journal-title":"J Autoimmun"},{"key":"7_CR94","doi-asserted-by":"crossref","unstructured":"Brooks WH, Le Dantec C, Pers JO et al. Epigenetics and autoimmunity. J Autoimmun 2010.","DOI":"10.1016\/j.jaut.2009.12.006"},{"key":"7_CR95","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61:288\u2013299.","journal-title":"Ann Neurol"},{"key":"7_CR96","doi-asserted-by":"crossref","unstructured":"Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol 2007.","DOI":"10.1002\/ana.21141"},{"key":"7_CR97","first-page":"258","volume":"2","author":"CM Poser","year":"1994","unstructured":"Poser CM. Notes on the pathogenesis of multiple sclerosis. Clin Neurosci 1994; 2:258\u2013265.","journal-title":"Clin Neurosci"},{"key":"7_CR98","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1074-7613(01)00210-2","volume":"15","author":"N Sutkowski","year":"2001","unstructured":"Sutkowski N, Conrad B, Thorley-Lawson DA et al. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001; 15:579\u2013589.","journal-title":"Immunity"},{"key":"7_CR99","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1177\/1352458508094641","volume":"14","author":"AK Tai","year":"2008","unstructured":"Tai AK, O\u2019Reilly EJ, Alroy KA et al. Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler 2008; 14:1175\u20131180.","journal-title":"Mult Scler"},{"key":"7_CR100","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/rmv.465","volume":"15","author":"T Christensen","year":"2005","unstructured":"Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005; 15:179\u2013211.","journal-title":"Rev Med Virol"},{"key":"7_CR101","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nn1319","volume":"7","author":"JM Antony","year":"2004","unstructured":"Antony JM, van Marle G, Opii W et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004; 7:1088\u20131095.","journal-title":"Nat Neurosci"},{"key":"7_CR102","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","volume":"291","author":"S Alotaibi","year":"2004","unstructured":"Alotaibi S, Kennedy J, Tellier R et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004; 291:1875\u20131879.","journal-title":"JAMA"},{"key":"7_CR103","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","volume":"67","author":"D Pohl","year":"2006","unstructured":"Pohl D, Krone B, Rostasy K et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67:2063\u20132065.","journal-title":"Neurology"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/rmv.503","volume":"16","author":"S Haahr","year":"2006","unstructured":"Haahr S, Hollsberg P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 2006; 16:297\u2013310.","journal-title":"Rev Med Virol"},{"key":"7_CR105","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/archneur.64.1.72","volume":"64","author":"TR Nielsen","year":"2007","unstructured":"Nielsen TR, Rostgaard K, Nielsen NM et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64:72\u201375.","journal-title":"Arch Neurol"},{"key":"7_CR106","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000260902","volume":"63","author":"AE Rolls","year":"2009","unstructured":"Rolls AE, Giovannoni G, Constantinescu CS et al. Multiple Sclerosis, Lymphoma and Nasopharyngeal Carcinoma: The Central Role of Epstein-Barr Virus? Eur Neurol 2009; 63:29\u201335.","journal-title":"Eur Neurol"},{"key":"7_CR107","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","volume":"63","author":"GN DeLorenze","year":"2006","unstructured":"DeLorenze GN, Munger KL, Lennette ET et al. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006; 63:839\u2013844.","journal-title":"Arch Neurol"},{"key":"7_CR108","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/1352458506071470","volume":"13","author":"TR Nielsen","year":"2007","unstructured":"Nielsen TR, Pedersen M, Rostgaard K et al. Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals. Mult Scler 2007; 13:420\u2013423.","journal-title":"Mult Scler"},{"key":"7_CR109","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","volume":"62","author":"P Sundstrom","year":"2004","unstructured":"Sundstrom P, Juto P, Wadell G et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004; 62:2277\u20132282.","journal-title":"Neurology"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1212\/WNL.42.9.1798","volume":"42","author":"PF Bray","year":"1992","unstructured":"Bray PF, Luka J, Bray PF et al. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992; 42:1798\u20131804.","journal-title":"Neurology"},{"key":"7_CR111","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","volume":"115","author":"S Cepok","year":"2005","unstructured":"Cepok S, Zhou D, Srivastava R et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115:1352\u20131360.","journal-title":"J Clin Invest"},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","volume":"80","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL. Molecular mimicry in T-cell-mediated autoimmunity: viral peptides activate human T-cell clones specific for myelin basic protein. Cell 1995; 80:695\u2013705.","journal-title":"Cell"},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni835","volume":"3","author":"HL Lang","year":"2002","unstructured":"Lang HL, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002; 3:940\u2013943.","journal-title":"Nat Immunol"},{"key":"7_CR114","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/13550280490261671","volume":"10","author":"T Holmoy","year":"2004","unstructured":"Holmoy T, Vartdal F. Cerebrospinal fluid T-cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B-cells. J Neurovirol 2004; 10:52\u201356.","journal-title":"J Neurovirol"},{"key":"7_CR115","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/13550280490499524","volume":"10","author":"T Holmoy","year":"2004","unstructured":"Holmoy T, Kvale EO, Vartdal F. Cerebrospinal fluid CD4+ T-cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. J Neurovirol 2004; 10:278\u2013283.","journal-title":"J Neurovirol"},{"key":"7_CR116","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2006.08.008","volume":"180","author":"F Gronen","year":"2006","unstructured":"Gronen F, Ruprecht K, Weissbrich B et al. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T-lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol 2006; 180:185\u2013192.","journal-title":"J Neuroimmunol"},{"key":"7_CR117","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204:2899\u20132912.","journal-title":"J Exp Med"},{"key":"7_CR118","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1586\/14737175.8.3.331","volume":"8","author":"A Ascherio","year":"2008","unstructured":"Ascherio A. Epstein-Barr virus in the development of multiple sclerosis. Expert Rev Neurother 2008; 8:331\u2013333.","journal-title":"Expert Rev Neurother"},{"key":"7_CR119","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1474-4422(08)70192-3","volume":"7","author":"D Franciotta","year":"2008","unstructured":"Franciotta D, Salvetti M, Lolli F et al. B-cells and multiple sclerosis. Lancet Neurol 2008; 7:852\u2013858.","journal-title":"Lancet Neurol"},{"key":"7_CR120","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/WCO.0b013e32832b4c8d","volume":"22","author":"M Salvetti","year":"2009","unstructured":"Salvetti M, Giovannoni G, Aloisi F. Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol 2009; 22:201\u2013206.","journal-title":"Curr Opin Neurol"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN, Stadelmann C, Rodig SJ et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009; 132:3318\u20133328.","journal-title":"Brain"},{"key":"7_CR122","doi-asserted-by":"crossref","unstructured":"Peferoen LA, Lamers F, Lodder LN et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2009.","DOI":"10.1093\/brain\/awp296"},{"key":"7_CR123","doi-asserted-by":"crossref","unstructured":"Torkildsen O, Stansberg C, Angelskar SM et al. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 2009.","DOI":"10.1111\/j.1750-3639.2009.00343.x"},{"key":"7_CR124","doi-asserted-by":"publisher","first-page":"e1727","DOI":"10.1371\/journal.pone.0001727","volume":"3","author":"AH Sawalha","year":"2008","unstructured":"Sawalha AH, Webb R, Han S et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 2008; 3:e1727.","journal-title":"PLoS ONE"},{"key":"7_CR125","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/gene.2008.29","volume":"9","author":"AH Sawalha","year":"2008","unstructured":"Sawalha AH, Jeffries M, Webb R et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008; 9:368\u2013378.","journal-title":"Genes Immun"},{"key":"7_CR126","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao C, Srinivasan L, Calado DP et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9:405\u2013414.","journal-title":"Nat Immunol"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","volume":"5","author":"K Paschos","year":"2009","unstructured":"Paschos K, Smith P, Anderton E et al. Epstein-barr virus latency in B-cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim PLoS Pathog 2009; 5:e1000492.","journal-title":"Bim PLoS Pathog"},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/0961203306070009","volume":"15","author":"JB Harley","year":"2006","unstructured":"Harley JB, Harley IT, Guthridge JM et al. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 2006; 15:768\u2013777.","journal-title":"Lupus"},{"key":"7_CR129","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/01.bor.0000240355.37927.94","volume":"18","author":"JA James","year":"2006","unstructured":"James JA, Harley JB, Scofield RH. Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol 2006; 18:462\u2013467.","journal-title":"Curr Opin Rheumatol"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","volume":"44","author":"JA James","year":"2001","unstructured":"James JA, Neas BR, Moser KL et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001; 44:1122\u20131126.","journal-title":"Arthritis Rheum"},{"key":"7_CR131","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1172\/JCI119856","volume":"100","author":"JA James","year":"1997","unstructured":"James JA, Kaufman KM, Farris AD et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100:3019\u20133026.","journal-title":"J Clin Invest"},{"key":"7_CR132","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT McClain","year":"2005","unstructured":"McClain MT, Heinlen LD, Dennis GJ et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11:85\u201389.","journal-title":"Nat Med"},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1084\/jem.181.2.453","volume":"181","author":"JA James","year":"1995","unstructured":"James JA, Gross T, Scofield RH et al. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B\/B\u2019-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995; 181:453\u2013461.","journal-title":"J Exp Med"},{"key":"7_CR134","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1365-3083.1999.00640.x","volume":"50","author":"MR Arbuckle","year":"1999","unstructured":"Arbuckle MR, Reichlin M, Harley JB et al. Shared early autoantibody recognition events in the development of anti-Sm B\/B\u2019 in human lupus. Scand J Immunol 1999; 50:447\u2013455.","journal-title":"Scand J Immunol"},{"key":"7_CR135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4049\/jimmunol.160.1.502","volume":"160","author":"JA James","year":"1998","unstructured":"James JA, Harley JB. A model of peptide-induced lupus autoimmune B-cell epitope spreading is strain specific and is not H-2 restricted in mice. J Immunol 1998; 160:502\u2013508.","journal-title":"J Immunol"},{"key":"7_CR136","first-page":"58","volume":"46","author":"MR Arbuckle","year":"1998","unstructured":"Arbuckle MR, Gross T, Scofield RH et al. Lupus humoral autoimmunity induced in a primate model by short peptide immunization. J Investig Med 1998; 46:58\u201365.","journal-title":"J Investig Med"},{"key":"7_CR137","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.148.7.2074","volume":"148","author":"JA James","year":"1992","unstructured":"James JA, Harley JB. Linear epitope mapping of an Sm B\/B\u2019 polypeptide. J Immunol 1992; 148:2074\u20132079.","journal-title":"J Immunol"},{"key":"7_CR138","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/art.21682","volume":"54","author":"MT McClain","year":"2006","unstructured":"McClain MT, Poole BD, Bruner BF et al. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum 2006; 54:360\u2013368.","journal-title":"Arthritis Rheum"},{"key":"7_CR139","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1749-6632.1997.tb52054.x","volume":"815","author":"JA James","year":"1997","unstructured":"James JA, Scofield RH, Harley JB. Lupus humoral autoimmunity after short peptide immunization. Ann NY Acad Sci 1997; 815:124\u2013127.","journal-title":"Ann NY Acad Sci"},{"key":"7_CR140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jaut.2004.06.001","volume":"23","author":"K Sundar","year":"2004","unstructured":"Sundar K, Jacques S, Gottlieb P et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 2004; 23:127\u2013140.","journal-title":"J Autoimmun"},{"key":"7_CR141","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1749-6632.2003.tb06051.x","volume":"987","author":"KM Kaufman","year":"2003","unstructured":"Kaufman KM, Kirby MY, Harley JB et al. Peptide mimics of a major lupus epitope of SmB\/B\u2019. Ann NY Acad Sci 2003; 987:215\u2013229.","journal-title":"Ann NY Acad Sci"},{"key":"7_CR142","first-page":"289","volume":"16","author":"M Incaprera","year":"1998","unstructured":"Incaprera M, Rindi L, Bazzichi A et al. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol 1998; 16:289\u2013294.","journal-title":"Clin Exp Rheumatol"},{"key":"7_CR143","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/eji.1830230525","volume":"23","author":"A Sabbatini","year":"1993","unstructured":"Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol 1993; 23:1146\u20131152.","journal-title":"Eur J Immunol"},{"key":"7_CR144","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2249.2004.02704.x","volume":"139","author":"M Yamazaki","year":"2005","unstructured":"Yamazaki M, Kitamura R, Kusano S et al. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjogren\u2019s syndrome patients with pulmonary involvements. Clin Exp Immunol 2005; 139:558\u2013568.","journal-title":"Clin Exp Immunol"},{"key":"7_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00430-004-0230-5","volume":"194","author":"SF Yu","year":"2005","unstructured":"Yu SF, Wu HC, Tsai WC et al. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol 2005; 194:115\u2013120.","journal-title":"Med Microbiol Immunol"},{"key":"7_CR146","doi-asserted-by":"publisher","first-page":"R295","DOI":"10.1186\/ar1181","volume":"6","author":"UY Moon","year":"2004","unstructured":"Moon UY, Park SJ, Oh ST et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 2004; 6:R295\u2013R302.","journal-title":"Arthritis Res Ther"},{"key":"7_CR147","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","volume":"172","author":"I Kang","year":"2004","unstructured":"Kang I, Quan T, Nolasco H et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 2004; 172:1287\u20131294.","journal-title":"J Immunol"},{"key":"7_CR148","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","volume":"174","author":"AJ Gross","year":"2005","unstructured":"Gross AJ, Hochberg D, Rand WM et al. EBV and systemic lupus erythematosus: a new perspective. J Immunol 2005; 174:6599\u20136607.","journal-title":"J Immunol"},{"key":"7_CR149","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.131.4.1797","volume":"131","author":"GC Tsokos","year":"1983","unstructured":"Tsokos GC, Magrath IT, Balow JE. Epstein-Barr virus induces normal B-cell responses but defective suppressor T-cell responses in patients with systemic lupus erythematosus. J Immunol 1983; 131:1797\u20131801.","journal-title":"J Immunol"},{"key":"7_CR150","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cellimm.2005.06.010","volume":"235","author":"BR Berner","year":"2005","unstructured":"Berner BR, Tary-Lehmann M, Yonkers NL et al. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Cell Immunol 2005; 235:29\u201338.","journal-title":"Cell Immunol"},{"key":"7_CR151","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.20042251","volume":"201","author":"S Yurasov","year":"2005","unstructured":"Yurasov S, Wardemann H, Hammersen J et al. Defective B-cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005; 201:703\u2013711.","journal-title":"J Exp Med"},{"key":"7_CR152","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1126\/science.1076963","volume":"298","author":"C Wakabayashi","year":"2002","unstructured":"Wakabayashi C, Adachi T, Wienands J et al. A distinct signaling pathway used by the IgG-containing B-cell antigen receptor. Science 2002; 298:2392\u20132395.","journal-title":"Science"},{"key":"7_CR153","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar1893","volume":"8","author":"KH Costenbader","year":"2006","unstructured":"Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 2006; 8:204.","journal-title":"Arthritis Res Ther"},{"key":"7_CR154","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.autrev.2006.08.014","volume":"6","author":"S Sawada","year":"2007","unstructured":"Sawada S, Takei M, Inomata H et al. What is after cytokine-blocking therapy, a novel therapeutic target-synovial Epstein-Barr virus for rheumatoid arthritis. Autoimmun Rev 2007; 6:126\u2013130.","journal-title":"Autoimmun Rev"},{"key":"7_CR155","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/03009740600718080","volume":"35","author":"JE Oliver","year":"2006","unstructured":"Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 2006; 35:169\u2013174.","journal-title":"Scand J Rheumatol"},{"key":"7_CR156","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jaut.2007.11.006","volume":"30","author":"O Sanchez-Pernaute","year":"2008","unstructured":"Sanchez-Pernaute O, Ospelt C, Neidhart M et al. Epigenetic clues to rheumatoid arthritis. J Autoimmun 2008; 30:12\u201320.","journal-title":"J Autoimmun"},{"key":"7_CR157","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJM197804202981602","volume":"298","author":"P Stastny","year":"1978","unstructured":"Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298:869\u2013871.","journal-title":"N Engl J Med"},{"key":"7_CR158","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205\u20131213.","journal-title":"Arthritis Rheum"},{"key":"7_CR159","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1006\/viro.1994.1421","volume":"202","author":"W Jilg","year":"1994","unstructured":"Jilg W, Bogedain C, Mairhofer H et al. The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC). Virology 1994; 202:974\u2013977.","journal-title":"Virology"},{"key":"7_CR160","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7","volume":"42","author":"JG Saal","year":"1999","unstructured":"Saal JG, Krimmel M, Steidle M et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum 1999; 42:1485\u20131496.","journal-title":"Arthritis Rheum"},{"key":"7_CR161","doi-asserted-by":"publisher","first-page":"e5778","DOI":"10.1371\/journal.pone.0005778","volume":"4","author":"DH Dreyfus","year":"2009","unstructured":"Dreyfus DH. Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity. PloS ONE 2009; 4:e5778.","journal-title":"PloS ONE"},{"key":"7_CR162","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1002\/art.10564","volume":"46","author":"M Massa","year":"2002","unstructured":"Massa M, Mazzoli F, Pignatti P et al. Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2721\u20132729.","journal-title":"Arthritis Rheum"},{"key":"7_CR163","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1001\/jama.1982.03330220034032","volume":"248","author":"CG Ray","year":"1982","unstructured":"Ray CG, Gall EP, Minnich LL et al. Acute polyarthritis associated with active Epstein-Barr virus infection. JAMA 1982; 248:2990\u20132993.","journal-title":"JAMA"},{"key":"7_CR164","first-page":"866","volume":"27","author":"S Blaschke","year":"2000","unstructured":"Blaschke S, Schwarz G, Moneke D et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 2000; 27:866\u2013873.","journal-title":"J Rheumatol"},{"key":"7_CR165","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/art.10933","volume":"48","author":"N Balandraud","year":"2003","unstructured":"Balandraud N, Meynard JB, Auger I et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 2003; 48:1223\u20131228.","journal-title":"Arthritis Rheum"},{"key":"7_CR166","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/intimm\/9.5.739","volume":"9","author":"M Takei","year":"1997","unstructured":"Takei M, Mitamura K, Fujiwara S et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol 1997; 9:739\u2013743.","journal-title":"Int Immunol"},{"key":"7_CR167","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10067-005-0194-x","volume":"26","author":"V Agarwal","year":"2007","unstructured":"Agarwal V, Singh R, Chauhan S. Remission of rheumatoid arthritis after acute disseminated varicella-zoster infection. Clin Rheumatol 2007; 26:779\u2013780.","journal-title":"Clin Rheumatol"},{"key":"7_CR168","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood.V88.8.3147.bloodjournal8883147","volume":"88","author":"F Pomponi","year":"1996","unstructured":"Pomponi F, Cariati R, Zancai P et al. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood 1996; 88:3147\u20133159.","journal-title":"Blood"},{"key":"7_CR169","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1172\/JCI112469","volume":"77","author":"R Fox","year":"1986","unstructured":"Fox R, Sportsman R, Rhodes G et al. Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. J Clin Invest 1986; 77:1539\u20131547.","journal-title":"J Clin Invest"},{"key":"7_CR170","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0090-1229(90)90002-8","volume":"54","author":"P Birkenfeld","year":"1990","unstructured":"Birkenfeld P, Haratz N, Klein G et al. Cross-reactivity between the EBNA-1 p107 peptide, collagen and keratin: implications for the pathogenesis of rheumatoid arthritis. Clin Immunol Immunopathol 1990; 54:14\u201325.","journal-title":"Clin Immunol Immunopathol"},{"key":"7_CR171","first-page":"1442","volume":"17","author":"T Kouri","year":"1990","unstructured":"Kouri T, Petersen J, Rhodes G et al. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol 1990; 17:1442\u20131449.","journal-title":"J Rheumatol"},{"key":"7_CR172","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00271874","volume":"9","author":"C Baboonian","year":"1989","unstructured":"Baboonian C, Halliday D, Venables PJ et al. Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1. Rheumatol Int 1989; 9:161\u2013166.","journal-title":"Rheumatol Int"},{"key":"7_CR173","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/art.1780330711","volume":"33","author":"J Petersen","year":"1990","unstructured":"Petersen J, Rhodes G, Roudier J et al. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1990; 33:993\u20131000.","journal-title":"Arthritis Rheum"},{"key":"7_CR174","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1073\/pnas.86.13.5104","volume":"86","author":"J Roudier","year":"1989","unstructured":"Roudier J, Petersen J, Rhodes GH et al. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA 1989; 86:5104\u20135108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR175","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM198111193052102","volume":"305","author":"G Tosato","year":"1981","unstructured":"Tosato G, Steinberg AD, Blaese RM. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 1981; 305:1238\u20131243.","journal-title":"N Engl J Med"},{"key":"7_CR176","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/ard.59.7.533","volume":"59","author":"E Toussirot","year":"2000","unstructured":"Toussirot E, Wendling D, Tiberghien P et al. Decreased T-cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis 2000; 59:533\u2013538.","journal-title":"Ann Rheum Dis"},{"key":"7_CR177","first-page":"239","volume":"32","author":"T Klatt","year":"2005","unstructured":"Klatt T, Ouyang Q, Flad T et al. Expansion of peripheral CD8+ CD28-T cells in response to Epstein-Barr viurs in patients with rheumatoid arthritis. J Rheumatol 2005; 32:239\u2013251.","journal-title":"J Rheumatol"},{"key":"7_CR178","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.4049\/jimmunol.157.10.4697","volume":"157","author":"J David-Ameline","year":"1996","unstructured":"David-Ameline J, Lim A, Davodeau F et al. Selection of T-cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis. J Immunol 1996; 157:4697\u20134706.","journal-title":"J Immunol"},{"key":"7_CR179","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1084\/jem.184.5.1791","volume":"184","author":"E Scotet","year":"1996","unstructured":"Scotet E, David-Ameline J, Peyrat MA et al. T-cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 1996; 184:1791\u20131800.","journal-title":"J Exp Med"},{"key":"7_CR180","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#","volume":"44","author":"D Baeten","year":"2001","unstructured":"Baeten D, Peene I, Union A et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001; 44:2255\u20132262.","journal-title":"Arthritis Rheum"},{"key":"7_CR181","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/art.21629","volume":"54","author":"F Pratesi","year":"2006","unstructured":"Pratesi F, Tommasi C, Anzilotti C et al. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 2006; 54:733\u2013741.","journal-title":"Arthritis Rheum"},{"key":"7_CR182","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43:155\u2013163.","journal-title":"Arthritis Rheum"},{"key":"7_CR183","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741\u20132749.","journal-title":"Arthritis Rheum"},{"key":"7_CR184","first-page":"171","volume":"84","author":"SY Gu","year":"1995","unstructured":"Gu SY, Huang TM, Ruan L et al. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand 1995; 84:171\u2013177.","journal-title":"Dev Biol Stand"},{"key":"7_CR185","first-page":"231","volume-title":"Herpesviruses and Immunity","author":"HJ Wolf","year":"1998","unstructured":"Wolf HJ, Morgan AJ. Epstein-Barr Virus vaccines. In: Medveczky P, Friedman H, Bendinelli M, eds. Herpesviruses and Immunity. New York: Plenum Press, 1998:231\u2013246."}],"container-title":["Advances in Experimental Medicine and Biology","Epigenetic Contributions in Autoimmune Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-8216-2_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T15:44:43Z","timestamp":1686239083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-8216-2_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9781441982155","9781441982162"],"references-count":185,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-8216-2_7","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}